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We present a case of recurrent, massive subcutaneous leiomyosarcoma involving the left
thigh in a 29-year-old male from Madagascar. The patient had earlier undergone local
resection of subcutaneous leiomyosarcoma a half year before. After surgical intervention,
local recurrence developed at this site and was rapidly growing. The patient was surgically
treated with a 2-cm-wide margin local excision in our hospital. The patient has remained
recurrence free at 1-year follow-up.
Copyright © 2015, the Authors. Published by Elsevier Inc. under copyright license from the
University of Washington. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Case report
A 29-year-old male from Madagascar presented to our hospi-
tal because of recurrence of subcutaneous leiomyosarcoma in
the left thigh after surgery performed a half year before. The
patient has not undergone chemotherapy and adjuvant
postoperative radiotherapy. Physical examination revealed a
mulberry appearance, tenderness, and poorly circumscribed
mass, with easy superficial hemorrhage when touched (Fig. 1).
The patient was in apparently good health. Full blood
count, biochemical test results, and tumor markers were
within the normal range. There was no inguinal lymphade-
nopathy. In addition, chest x-ray and electrocardiography
were within normal limits.
Magnetic resonance imaging (MRI) revealed a multi-
lobulated, heterogeneous, subcutaneous lesion thatmeasured
9.0 cm  5.1 cm  7.2 cm in the lateroposterior aspect of the
left thigh (Fig. 2). In addition, multiple hemorrhages in thelared that no competing i
m (G. Chuanping).
blished by Elsevier Inc. u
ND license (http://creativmass demonstrated high signal intensity in T1- and
T2-weighted images (Figs. 3 and 4). After intravenous
contrast-enhanced MRI, the mass appeared prominent,
heterogeneous, and enhanced (Figs. 5 and 6).
The mass originated from a subcutaneous region at a
lateroposterior aspect of the left thigh and broke out of the
epidermis. The adjacent deep fascia was free of involvement.
The patient underwent a wide local excision with 2-cm
lateral margins. All surgical margins were negative. Gross
specimen appeared as a fleshy, gray-white, glistening, and
predominantly cystic necrotic mass with hemorrhage
(Fig. 7).
Histopathologic examination showed a poorly delineated
tumor with intersecting, sharply marginated fascicles of
spindle cells with eosinophilic cytoplasm and elongated,
blunt-ended, and hyperchromatic nuclei (Fig. 8). Immuno-
histochemically, the cells were positive for actin and desmin
(Fig. 9).nterests exist.
nder copyright license from the University of Washington. This is
ecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1 e A recurrent subcutaneous leiomyosarcoma
involving the patient's left thigh, with a loss of the
continuity of focal skin.
Fig. 3 e Axial T1-weighted magnetic resonance image
demonstrates predominantly isointense mass and nodular
focus of high signal of hemorrhage (arrow).
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Superficial leiomyosarcomas are rare malignant tumors
accounting for 4%-6.5% of all soft-tissue sarcomas [1]. They are
divided into cutaneous or dermal and subcutaneous leiomyo-
sarcomas depending on their location in the skin and pre-
sumed site of origin [1]. Subcutaneous leiomyosarcoma arises
from the smooth muscle lining of arterioles or veins in sub-
cutaneous tissue and accounts for 1%-2% of all soft-tissue
sarcomas [2]. They may arise anywhere on the body, and the
thigh has been reported as themost frequently affected site [3].
Subcutaneous leiomyosarcomamay occur at any age,most
commonly between the ages of 40 and 60 years [2]. It usually
presents as a hemispherical skin elevation ranging from 0.6 to
5 cm in diameter and larger than its dermal counterparts [3].
Subcutaneous leiomyosarcomas are typically fast growing
and without surface changes [3]. However, our recurrent case
presentedwithmulberry appearance andwas associated withFig. 2 e Axial T1-weighted magnetic resonance image
demonstrates the lobulated mass isointense to muscle and
lack of deep fascia involvement.skin ulceration. A review of the literature suggests that the
case reported here is the largest recurrent subcutaneous
leiomyosarcoma arising in extremities reported so far.
The imaging features of subcutaneous leiomyosarcoma
are typically nonspecific [1]. Lesions are typically isointense toFig. 4 e Coronal short time inversion recovery magnetic
resonance image demonstrates lobulated, high-signal-
intensity mass, and the hemorrhage shows high signal
intensity (arrow).
Fig. 5 e Coronal T1-weighted contrast-enhanced
magnetic resonance image demonstrates prominent,
patchy-enhancing subcutaneous mass.
Fig. 6 e Axial T1-weighted contrast-enhanced
magnetic resonance image demonstrates prominent,
patchy-enhancing subcutaneous mass.
Fig. 7 e Gross specimen shows a multiple necrotic mass
with typical fleshy appearance and hemorrhage on its
cut surface.
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relative to muscle on T2-weighted images, with prominent
contrast enhancement. Large lesions are usually more
heterogeneous because of the presence of hemorrhage,
necrosis, and cystic changes, whereas microcalcifications
maybedemonstrated in10%-15%of thecasesonradiographsor
computed tomographyscans [4].MRI shouldbeused for staging
purposes in subcutaneous tumors larger than 3-5 cm [4].
As subcutaneous leiomyosarcoma is resistant to radiation
and chemotherapy, early surgical excisionwith widemargins is
the treatment recommendation [3,5]. Prognosis after excision is
generally considered poor. Factors that have correlated withFig. 8 e Microscopic examinations revealing the lesion to
be of predominantly fascicular pattern, with tumor bundles
intersecting each other at wide angles. The individual
tumor cells have elongated blunt-ended nuclei and
acidophilic fibrillary cytoplasm. Cytoplasmic vacuoles are
located at both ends of the nuclei. Some of the tumor
cells show large bizarre appearance.
Fig. 9 e Immunohistochemistry: the tumor is positive for
smooth muscle actin (original magnification £100).
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necrosis, deep tumors with fascia involvement, and intra-
tumoral vascular invasion [2,6]. The risks of local recurrence
haverangedfrom14%to42%andhavebeenreportedevenaftera
wideexcision.Recurrenceshavebeenreportedafter theremovalof very small primary tumorsmeasuring 0.5 cm,whereas 50%of
the tumors recurwithin 4-18months after initial diagnosis [3,7].r e f e r e n c e s
[1] Salemis NS. Recurrent subcutaneous trunk leiomyosarcoma:
management and review of the literature. J Nat Sci Biol Med
2013;4(1):238e42.
[2] Yajima K, Shirai Y, Fujita N, Sato D, Umezu H, Hatakeyama K.
A giant subcutaneous leiomyosarcoma arising in the inguinal
region. World J Surg Oncol 2005;3(1):14.
[3] Fields JP, Helwig EB. Leiomyosarcoma of the skin and
subcutaneous tissue. Cancer 1981;47(1):156e69.
[4] Morel M, Taieb S, Penel N, Mortier L, Vanseymortier L,
Robin YM, et al. Imaging of the most frequent soft-tissue
sarcomas. Skeletal Radiol 2011;40(3):271e84.
[5] Tsutsumida A, Yoshida T, Yamamoto Y, Itoh T, Minakawa H,
Sugihara T. Management of superficial leiomyosarcoma: a
retrospective study of 10 cases. Plast Reconstr Surg
2005;116(1):8e12.
[6] Svarvar C, B€ohling T, Berlin O, Gustafson P, Folleras G,
Bjerkehagen B, et al. Clinical course of nonvisceral soft tissue
leiomyosarcoma in 225 patients from the Scandinavian
Sarcoma Group. Cancer 2007;109(2):282e91.
[7] Fauth CT, Bruecks AK, Temple W, Arlette JP, DiFrancesco LM.
Superficial leiomyosarcoma: a clinicopathologic review and
update. J Cutan Pathol 2010;37(2):269e76.
